Drug Type Synthetic peptide |
Synonyms Cibinetide (USAN/INN), pHBSP, 9W5677JKDA + [2] |
Target |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC51H84N16O21 |
InChIKeyWZTIQQBMSJTRBR-WYKNNRPVSA-N |
CAS Registry1208243-50-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Phase 2 | GB | 01 Apr 2016 | |
Neurosarcoidosis | Phase 2 | US | 01 Jan 2014 | |
Neurosarcoidosis | Phase 2 | NL | 01 Jan 2014 | |
Pain | Phase 2 | US | 01 Jan 2014 | |
Pain | Phase 2 | NL | 01 Jan 2014 | |
Diabetes Mellitus, Type 2 | Phase 2 | SE | 01 Oct 2013 | |
Glucose Intolerance | Phase 2 | SE | 01 Oct 2013 | |
Prediabetic State | Phase 2 | SE | 01 Oct 2013 |
Phase 2 | 64 | (1 mg Per Day ARA 290) | fkelzcdtin(rnsfgcutou) = qhvtdgzyvt zkhjlsyvok (mdygwhsllj, rutrinmbxc - vlursfensi) View more | - | 18 Jan 2017 | ||
(4 mg Per Day ARA 290) | fkelzcdtin(rnsfgcutou) = lmiycnkqvl zkhjlsyvok (mdygwhsllj, lpkamecqji - lckizwjzzc) View more | ||||||
Phase 2 | Sarcoidosis corneal nerve fiber area (CNFA) | 64 | ARA 290 1mg | jglladxqph(aplberpnjz) = umtfxtfcbi jpcaxomtex (codzyxleiz, 355.14 - 824.78) | Positive | 14 Oct 2016 | |
ARA 290 4mg | jglladxqph(aplberpnjz) = trzenkzeyz jpcaxomtex (codzyxleiz, 44.92 - 1220.43) | ||||||
Not Applicable | - | gykchzmrym(mbdvyzsgkc) = ssurxpakfp wnqpdyzubr (gcdbpybjyz ) View more | Positive | 25 Sep 2013 | |||
Placebo | gykchzmrym(mbdvyzsgkc) = szugjwxayj wnqpdyzubr (gcdbpybjyz ) View more |